Roberto Pedro Rosenkranz
Presidente presso Grama Ventures LLC
Profilo
Roberto Pedro Rosenkranz is the founder of ROXRO Pharma, Inc. which was founded in 1999.
He held the position of Chairman & Chief Executive Officer from 1999 to 2010.
Dr. Rosenkranz's current jobs include Director at Ronald & Ann Williams Charitable Foundation and President & Director at Grama Ventures LLC.
Dr. Rosenkranz's former jobs include Executive Chairman at Altos Therapeutics LLC from 2012 to 2017, Director at Gemini Genomics Plc, Director at CombiMatrix Corp., Independent Director at FibroGen, Inc. from 2010 to 2020, Operations Director at Roche Laboratories, Inc. from 1994 to 1996, Director at Pherin Pharmaceuticals, Inc., Director at Medcenter Solutions Do Brasil SA, President & Chief Operating Officer at Scios, Inc. from 1996 to 1997, and Principal at Syntex Corp.
from 1992 to 1994.
Dr. Rosenkranz's education includes an undergraduate degree from Stanford University in 1971, an MBA degree from Santa Clara University in 1989, and a doctorate degree from the University of California, Davis in 1980.
Posizioni attive di Roberto Pedro Rosenkranz
| Società | Posizione | Inizio |
|---|---|---|
| Ronald & Ann Williams Charitable Foundation | Direttore/Membro del Consiglio | - |
| Grama Ventures LLC | Presidente | - |
Precedenti posizioni note di Roberto Pedro Rosenkranz
| Società | Posizione | Fine |
|---|---|---|
| FIBROGEN, INC. | Direttore/Membro del Consiglio | 30/06/2020 |
| Altos Therapeutics LLC | Presidente | 01/01/2017 |
ROXRO Pharma, Inc.
 ROXRO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ROXRO Pharma, Inc. develops hospital strength acute pain products. Its products include ROX-888, an intranasal formulation for the treatment of dental and postoperative pain; ROX-828, a non-opioid and non-triptan intranasal product for the treatment of migraine; and SPRIX nasal spray for the short-term management of acute moderate to moderately severe pain that requires analgesia at the opioid level. The company was founded by Michael E Fitzgerald, Roger Whiting and Roberto Pedro Rosenkranz in 1999 and is headquartered in Menlo Park, CA. | Amministratore Delegato | 01/12/2010 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Presidente | 01/01/1997 |
Roche Laboratories, Inc.
 Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | Direttore operativo | 01/07/1996 |
Formazione di Roberto Pedro Rosenkranz
| Stanford University | Undergraduate Degree |
| Santa Clara University | Masters Business Admin |
| University of California, Davis | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| Aziende private | 11 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
| Syntex Corp. | Health Technology |
Gemini Genomics Plc
 Gemini Genomics Plc Miscellaneous Commercial ServicesCommercial Services Part of Laboratory Corp. of America Holdings, Gemini Genomics Plc is a British company that provides clinical genomics services. The company is based in Cambridge, UK. The company was founded by Michael Edward Fitzgerald, Paul James Kelly. | Commercial Services |
CombiMatrix Corp.
 CombiMatrix Corp. BiotechnologyHealth Technology CombiMatrix Corp. engages in the provision of clinical diagnostic services. It offers cytogenomic testing for preimplantation genetic testing, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. The company was founded in October 1995 and is headquartered in Irvine, CA. | Health Technology |
ROXRO Pharma, Inc.
ROXRO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ROXRO Pharma, Inc. develops hospital strength acute pain products. Its products include ROX-888, an intranasal formulation for the treatment of dental and postoperative pain; ROX-828, a non-opioid and non-triptan intranasal product for the treatment of migraine; and SPRIX nasal spray for the short-term management of acute moderate to moderately severe pain that requires analgesia at the opioid level. The company was founded by Michael E Fitzgerald, Roger Whiting and Roberto Pedro Rosenkranz in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Roche Laboratories, Inc.
Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | Distribution Services |
Pherin Pharmaceuticals, Inc.
 Pherin Pharmaceuticals, Inc. BiotechnologyHealth Technology Pherin Pharmaceuticals, Inc. operates as a clinical stage company. It focuses on the development of its proprietary compounds pherines, for the acute treatment of neuropsychiatric and neuroendocrine conditions. The firm’s products include Aloradine, PH10, Salubrin-HF and PH15. The company was founded in 1991 and is headquartered in Los Altos, CA. | Health Technology |
| Altos Therapeutics LLC | |
| Ronald & Ann Williams Charitable Foundation | |
| Medcenter Solutions Do Brasil SA | |
| Grama Ventures LLC |
- Borsa valori
- Insiders
- Roberto Pedro Rosenkranz
